Company

Keymed Biosciences Co.Ltd

As of the edition of 20 October 2026, Keymed Biosciences Co.Ltd runs 11 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active10
Status not established1
Total11

Where its trials are

  • Immune system: 36 trials led
  • Skin and connective tissue: 22 trials led
  • Inherited and neonatal: 18 trials led